Pathogenesis and Management of Acute Necrotizing Encephalopathy

References

• Mizuguchi M, Abe J, Mikkaichi K, et al. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry. 1995;58(5):555–561. doi:10.1136/jnnp.58.5.555.
   PubMed Web of Science ®Google Scholar
• Wu X, Wu W, Pan W, et al. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm. 2015;2015:1–10. 2015. doi:10.1155/2015/792578
   Web of Science ®Google Scholar
• Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in japan and taiwan. Brain Dev. 1997;19(2):81–92. doi:10.1016/S0387-7604(96)00063-0.
   PubMed Web of Science ®Google Scholar
• Ochi N, Takahashi K, Yamane H, et al. Acute necrotizing encephalopathy in an adult with influenza an infection. ther clin risk manag. 2018;14:753–756. doi:10.2147/TCRM.S160111
   Google Scholar
• Fernandez-Blazquez A, Castanon-Apilanez M, Alvarez-Arguelles ME, et al. Neuroinvasion of influenza A/H3N2: a fatal case in an immunocompetent adult. J Neurovirol. 2019;25(2):275–279. doi:10.1007/s13365-018-0690-9
   PubMed Web of Science ®Google Scholar
• Lee YJ, Hwang SK, Kwon S. Acute necrotizing encephalopathy in children: a long way to go. J Korean Med Sci. 2019;34(19):e143. doi:10.3346/jkms.2019.34.e143.
   PubMed Web of Science ®Google Scholar
• Rettenmaier LA, Abdel-Wahed L, Abdelmotilib H, et al. COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology. J Neurovirol. 2022;28(1):172–176. doi:10.1007/s13365-021-01042-3
   PubMed Web of Science ®Google Scholar
• Pongpitakmetha T, Hemachudha P, Rattanawong W, et al. COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement. BMC Infect Dis. 2022;22(1):640. doi:10.1186/s12879-022-07610-0.
   PubMed Web of Science ®Google Scholar
• Ziemele D, Kauke G, Skrejane K, et al. A fatal case of COVID-19-associated acute necrotizing encephalopathy. Eur J Neurol. 2021;28(11):3870–3872. doi:10.1111/ene.14966
   PubMed Web of Science ®Google Scholar
• Dixon L, Varley J, Gontsarova A, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol(r) Neuroimmunol Neuroinflammation. 2020;7(5):e789. doi:10.1212/NXI.0000000000000789
   PubMed Web of Science ®Google Scholar
• Holla VV, Gohel AB, Kartik N, et al. Acute necrotizing encephalopathy as a complication of chikungunya infection. Neurol India. 2021;69(2):490–492. doi:10.4103/0028-3886.314525
   PubMed Web of Science ®Google Scholar
• Huang SM, Chen CC, Chiu PC, et al. Acute necrotizing encephalopathy of childhood associated with influenza type B virus infection in a 3-year-old girl. J Child Neurol. 2004;19(1):64–67. doi:10.1177/08830738040190010709
   PubMed Web of Science ®Google Scholar
• Tabarki B, Thabet F, Al Shafi S, et al. Acute necrotizing encephalopathy associated with enterovirus infection. Brain Dev. 2013;35(5):454–457. doi:10.1016/j.braindev.2012.07.001
   PubMed Web of Science ®Google Scholar
• Tran TD, Kubota M, Takeshita K, et al. Varicella-associated acute necrotizing encephalopathy with a good prognosis. Brain Dev. 2001;23(1):54–57. doi:10.1016/S0387-7604(00)00199-6
   PubMed Web of Science ®Google Scholar
• Ohsaka M, Houkin K, Takigami M, et al. Acute necrotizing encephalopathy associated with human herpesvirus-6 infection. Pediatr Neurol. 2006;34(2):160–163. doi:10.1016/j.pediatrneurol.2005.07.007
   PubMed Web of Science ®Google Scholar
• Mariotti P, Iorio R, Frisullo G, et al. Acute necrotizing encephalopathy during novel influenza a (H1N1) virus infection. Ann Neurol. 2010;68(1):111–114. doi:10.1002/ana.21996
   PubMed Web of Science ®Google Scholar
• Stevanovic V, Barusic Z, Viskovic K, et al. Acute necrotizing encephalopathy of childhood associated with human herpes virus 6 in Croatia. Neurol Sci. 2019;40(3):639–641. doi:10.1007/s10072-018-3623-8
   PubMed Web of Science ®Google Scholar
• Huber JN, Berg AD, Bula-Rudas F. Acute necrotizing encephalopathy due to streptococcus pneumoniae: an uncommon pathogen in a devastating disease. Pediatr Neurol. 2020;108:126–127. doi: 10.1016/j.pediatrneurol.2020.03.002
   PubMed Web of Science ®Google Scholar
• Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119–e120. doi:10.1148/radiol.2020201187
   PubMed Web of Science ®Google Scholar
• Aydin H, Ozgul E, Agildere AM. Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings. Pediatr Radiol. 2010;40(7):1281–1284. doi:10.1007/s00247-009-1498-9.
   PubMed Web of Science ®Google Scholar
• Fan X, Huang L, Li S, et al. Clinical evaluation of acute necrotizing encephalopathy in children. Front Pediatr. 2022;10:947693. doi:10.3389/fped.2022.947693
   PubMed Web of Science ®Google Scholar
• Goo HW, Choi CG, Yoon CH, et al. Acute necrotizing encephalopathy: diffusion MR imaging and localized proton MR spectroscopic findings in two infants. Korean J Radiol. 2003;4(1):61–65. doi:10.3348/kjr.2003.4.1.61
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tamura T, Nagai Y, et al. MRI gadolinium enhancement precedes neuroradiological findings in acute necrotizing encephalopathy. Brain Dev. 2013;35(10):921–924. doi:10.1016/j.braindev.2012.11.011
   PubMed Web of Science ®Google Scholar
• Montagne A, Toga AW, Zlokovic BV. Blood–brain barrier permeability and gadolinium: benefits and potential pitfalls in research. JAMA Neurol. 2016;73(1):13–14. doi:10.1001/jamaneurol.2015.2960.
   PubMed Web of Science ®Google Scholar
• Shukla P, Mandalla A, Elrick MJ, et al. Clinical manifestations and pathogenesis of acute necrotizing encephalopathy: the interface between systemic infection and neurologic injury. Front Neurol. 2021;12:628811.
   PubMed Web of Science ®Google Scholar
• Fajgenbaum DC, June CH, Longo DL. Cytokine Storm. N Engl J Med. 2020;383(23):2255–2273. doi:10.1056/NEJMra2026131.
   PubMed Web of Science ®Google Scholar
• Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116–125. doi:10.1016/j.yfrne.2011.12.002.
   PubMed Web of Science ®Google Scholar
• Koh JC, Murugasu A, Krishnappa J, et al. Favorable outcomes with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy of childhood. Pediatr Neurol. 2019;98:80–84. doi:10.1016/j.pediatrneurol.2019.04.009
   PubMed Web of Science ®Google Scholar
• Ho JHY, Lee CYM, Chiong YK, et al. SARS-CoV-2-related acute necrotizing encephalopathy of childhood with good response to tocilizumab in an adolescent. Pediatr Neurol. 2023;139:65–69. doi:10.1016/j.pediatrneurol.2022.11.010
   PubMed Web of Science ®Google Scholar
• Lin YY, Lee KY, Ro LS, et al. Clinical and cytokine profile of adult acute necrotizing encephalopathy. Biomed J. 2019;42(3):178–186. doi:10.1016/j.bj.2019.01.008.
   PubMed Web of Science ®Google Scholar
• Neilson DE, Adams MD, Orr CM, et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84(1):44–51. doi:10.1016/j.ajhg.2008.12.009.
   PubMed Web of Science ®Google Scholar
• Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127–148. doi:10.1093/intimm/dxaa078.
   PubMed Web of Science ®Google Scholar
• Lin YJ, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4). doi:10.3390/cells9040880.
   Web of Science ®Google Scholar
• Yao X, Huang J, Zhong H, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2):125–139. doi:10.1016/j.pharmthera.2013.09.004
   PubMed Web of Science ®Google Scholar
• Neilson DE, Eiben RM, Waniewski S, et al. Autosomal dominant acute necrotizing encephalopathy. Neurology. 2003;61(2):226–230. doi:10.1212/01.WNL.0000073544.28775.1A
   PubMed Web of Science ®Google Scholar
• Wolf K, Schmitt-Mechelke T, Kollias S, et al. Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis. J Neurol. 2013;260(6):1545–1553. doi:10.1007/s00415-012-6825-7.
   PubMed Web of Science ®Google Scholar
• Bloch C, Suter B, Fischmann A, et al. Only a touch of the flu? the simultaneous manifestation of acute necrotizing encephalopathy in two consanguineous patients. Open Forum Infect Dis. 2015;2(2):ofv013. doi:10.1093/ofid/ofv013
   PubMed Web of Science ®Google Scholar
• Singh RR, Sedani S, Lim M, et al. RANBP2 mutation and acute necrotizing encephalopathy: 2 cases and a literature review of the expanding clinico-radiological phenotype. Eur J Paediatr Neurol. 2015;19(2):106–113. doi:10.1016/j.ejpn.2014.11.010
   PubMed Web of Science ®Google Scholar
• Ndondo AP, Eley B, Wilmshurst JM, et al. PostInfectious autoimmunity in the central (cns) and peripheral (pns) nervous systems: an African perspective. Front Immunol. 2022;13:833548. doi:10.3389/fimmu.2022.833548
   PubMed Web of Science ®Google Scholar
• Neilson DE. The interplay of infection and genetics in acute necrotizing encephalopathy. Curr Opin Pediatr. 2010;22(6):751–757. doi:10.1097/MOP.0b013e3283402bfe.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Saitoh M, Miyagawa T, et al. Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy. Genes Immun. 2016;17(6):367–369. doi:10.1038/gene.2016.32
   PubMed Web of Science ®Google Scholar
• Oh HH, Kwon SH, Kim CW, et al. Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children. J Korean Med Sci. 2004;19(3):426–430. doi:10.3346/jkms.2004.19.3.426
   PubMed Web of Science ®Google Scholar
• Shinohara M, Saitoh M, Takanashi J, et al. Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. Brain Dev. 2011;33(6):512–517. doi:10.1016/j.braindev.2010.09.002.
   PubMed Web of Science ®Google Scholar
• Wataya K, Akanuma J, Cavadini P, et al. Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: functional analysis and association with polymorphic haplotypes and two clinical phenotypes. Hum Mutat. 1998;11(5):377–386. doi:10.1002/(SICI)1098-1004(1998)11:5<377:AID-HUMU5>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Kasai M, Omae Y, Khor SS, et al. Protective association of HLA-DPB1*04: 01: 01 with acute encephalopathy with biphasic seizures and late reduced diffusion identified by HLA imputation. Genes Immun. 2022;23(3–4):123–128. doi:10.1038/s41435-022-00170-y
   PubMed Web of Science ®Google Scholar
• Chen Y, Mizuguchi H, Yao D, et al. Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy. FEBS Lett. 2005;579(10):2040–2044. doi:10.1016/j.febslet.2005.02.050
   PubMed Web of Science ®Google Scholar
• Fukao T, Mitchell GA, Song XQ, et al. Succinyl-CoA: 3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics. 2000;68(2):144–151. doi:10.1006/geno.2000.6282
   PubMed Web of Science ®Google Scholar
• Kubota M, Chida J, Hoshino H, et al. Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children. Brain Dev. 2012;34(1):20–27. doi:10.1016/j.braindev.2010.12.012
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kanazawa H, Hoshino A, et al. Acute necrotizing encephalopathy and a carnitine palmitoyltransferase 2 variant in an adult. J Clin Neurosci. 2019;61:264–266. doi:10.1016/j.jocn.2018.11.045
   PubMed Web of Science ®Google Scholar
• Virhammar J, Kumlien E, Fallmar D, et al. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology. 2020;95(10):445–449. doi:10.1212/WNL.0000000000010250
   PubMed Web of Science ®Google Scholar
• Frontera JA, Lewis A, Yaghi S, et al. Reader response: acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology. 2021;97(5):252. doi:10.1212/WNL.0000000000012357.
   PubMed Web of Science ®Google Scholar
• Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758–763. doi:10.1038/s41586-022-05542-y
   PubMed Web of Science ®Google Scholar
• Espíndola OM, Siqueira M, Soares CN, et al. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid. Int J Infect Dis. 2020;96:567–569. doi:10.1016/j.ijid.2020.05.123
   PubMed Web of Science ®Google Scholar
• Erdil E, Vural E, Koytak PK, et al. Successful treatment of influenza B associated acute necrotizing encephalopathy in an adult using combination of high dose oseltamivir-IVIG-pulse metylprednisolone. Acta Neurol Belg. 2021;121(6):1863–1865. doi:10.1007/s13760-020-01462-8
   PubMed Web of Science ®Google Scholar
• Okumura A, Abe S, Kidokoro H, et al. Acute necrotizing encephalopathy: a comparison between influenza and noninfluenza cases. Microbiol Immunol. 2009;53(5):277–280. doi:10.1111/j.1348-0421.2009.00124.x.
   PubMed Web of Science ®Google Scholar
• Levine JM, Ahsan N, Ho E, et al. Genetic acute necrotizing encephalopathy associated with ranbp2: clinical and therapeutic implications in pediatricsVol. 43. Mult Scler Relat Disord; 2020p. 102194. doi:10.1016/j.msard.2020.102194.
   Google Scholar
• Alsolami A, Shiley K. Successful treatment of influenza-associated acute necrotizing encephalitis in an adult using high-dose oseltamivir and methylprednisolone: case report and literature review. Open Forum Infect Dis. 2017;4(3):ofx145. doi:10.1093/ofid/ofx145.
   PubMed Web of Science ®Google Scholar
• Wang KY, Singer HS, Crain B, et al. Hypoxic-ischemic encephalopathy mimicking acute necrotizing encephalopathy. Pediatr Neurol. 2015;52(1):110–114. doi:10.1016/j.pediatrneurol.2014.09.009
   PubMed Web of Science ®Google Scholar
• Togashi T, Matsuzono Y, Narita M, et al. Influenza-associated acute encephalopathy in Japanese children in 1994-2002. Virus Res. 2004;103(1–2):75–78. doi:10.1016/j.virusres.2004.02.016
   PubMed Web of Science ®Google Scholar
• Oki J, Yoshida H, Tokumitsu A, et al. Serial neuroimages of acute necrotizing encephalopathy associated with human herpesvirus 6 infection. Brain Dev. 1995;17(5):356–359. doi:10.1016/0387-7604(95)00077-O
   PubMed Web of Science ®Google Scholar
• Okumura A, Mizuguchi M, Aiba H, et al. Delirious behavior in children with acute necrotizing encephalopathy. Brain Dev. 2009;31(8):594–599. doi:10.1016/j.braindev.2008.09.002
   PubMed Web of Science ®Google Scholar
• Okumura A, Mizuguchi M, Kidokoro H, et al. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev. 2009;31(3):221–227. doi:10.1016/j.braindev.2008.03.005
   PubMed Web of Science ®Google Scholar
• Albayram S, Bilgi Z, Selcuk H, et al. Diffusion-weighted MR imaging findings of acute necrotizing encephalopathy. AJNR Am J Neuroradiol. 2004;25(5):792–797.
   PubMed Web of Science ®Google Scholar
• Biswas A, Varman M, Gunturi A, et al. Teaching NeuroImages: acute necrotizing encephalopathy of childhood: neuroimaging findings. Neurology. 2018;90(2):e177–e178. doi:10.1212/WNL.0000000000004800
   PubMed Web of Science ®Google Scholar
• San Millan B, Teijeira S, Penin C, et al. Acute necrotizing encephalopathy of childhood: report of a Spanish case. Pediatr Neurol. 2007;37(6):438–441. doi:10.1016/j.pediatrneurol.2007.07.007
   PubMed Web of Science ®Google Scholar
• Venkatesan A, Murphy OC. Viral Encephalitis. Viral Encephalitis Neurol Clin. 2018;36(4):705–724. doi:10.1016/j.ncl.2018.07.001.
   PubMed Web of Science ®Google Scholar
• Endres D, Leypoldt F, Bechter K, et al. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. Eur Arch Psychiatry Clin Neurosci. 2020;270(7):803–818. doi:10.1007/s00406-020-01113-2
   PubMed Web of Science ®Google Scholar
• Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169(4):397–403. doi:10.1001/jamapediatrics.2014.3269.
   PubMed Web of Science ®Google Scholar
• Sinha S, Kataria A, Kolla BP, et al. Wernicke Encephalopathy—Clinical Pearls. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc. 2019;94(6):1065–1072. doi:10.1016/j.mayocp.2019.02.018
   PubMed Web of Science ®Google Scholar
• Baertling F, Rodenburg RJ, Schaper J, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry. 2014;85(3):257–265. doi:10.1136/jnnp-2012-304426
   PubMed Web of Science ®Google Scholar
• Howard RS, Holmes PA, Siddiqui A, et al. Hypoxic-ischemic brain injury: imaging and neurophysiology abnormalities related to outcome. QJM. 2012;105(6):551–561. doi:10.1093/qjmed/hcs016
   PubMed Web of Science ®Google Scholar
• Wong AM, Toh CH. Spectrum of neuroimaging mimics in children with COVID-19 infection. Biomed J. 2022;45(1):50–62. doi:10.1016/j.bj.2021.11.005.
   PubMed Web of Science ®Google Scholar
• Simone IL, Carrara D, Tortorella C, et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology. 2002;59(12):1922–1928. doi:10.1212/01.WNL.0000036907.37650.8E
   PubMed Web of Science ®Google Scholar
• De Vivo DC. Leigh syndrome: historical perspective and clinical variations. BioFactors. 1998;7(3):269–271. doi:10.1002/biof.5520070325.
   PubMedGoogle Scholar
• Kansagra SM, Gallentine WB. Cytokine storm of acute necrotizing encephalopathy. Pediatr Neurol. 2011;45(6):400–402. doi:10.1016/j.pediatrneurol.2011.09.007.
   PubMed Web of Science ®Google Scholar
• Bensaidane MR, Picher-Martel V, Émond F, et al. Case report: acute necrotizing encephalopathy following COVID-19 Vaccine. Front Neurol. 2022;13:13. doi:10.3389/fneur.2022.872734
   Web of Science ®Google Scholar
• Delamarre L, Gollion C, Grouteau G, et al. COVID-19-associated acute necrotizing encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fiber network. J Neurol Neurosurg Psychiatry. 2020;91(9):1004–1006. doi:10.1136/jnnp-2020-323678
   PubMed Web of Science ®Google Scholar
• Shen Q, Wang YE, Truong M, et al. RanBP2/Nup358 enhances miRNA activity by sumoylating Argonautes. PLoS Genet. 2021;17(2):e1009378. doi:10.1371/journal.pgen.1009378
   PubMed Web of Science ®Google Scholar
• Akiyoshi K, Hamada Y, Yamada H, et al. Acute necrotizing encephalopathy associated with hemophagocytic syndrome. Pediatr Neurol. 2006;34(4):315–318. doi:10.1016/j.pediatrneurol.2005.08.030
   PubMed Web of Science ®Google Scholar
• Kurisu K, Yenari MA. Therapeutic hypothermia for ischemic stroke; pathophysiology and future promise. Neuropharmacology. 2018;134(Pt B):302–309. doi:10.1016/j.neuropharm.2017.08.025.
   PubMedGoogle Scholar
• Vargas WS, Merchant S, Solomon G. Favorable outcomes in acute necrotizing encephalopathy in a child treated with hypothermia. Pediatr Neurol. 2012;46(6):387–389. doi:10.1016/j.pediatrneurol.2012.03.001.
   PubMed Web of Science ®Google Scholar
• Larsh T, Hsich G. Temporal course of imaging and laboratory findings in a child with fulminant acute necrotizing encephalopathy. Pediatr Neurol. 2020;102:74–75. doi: 10.1016/j.pediatrneurol.2019.05.003
   PubMed Web of Science ®Google Scholar
• Rivera-Lara L, Zhang J, Muehlschlegel S. Therapeutic hypothermia for acute neurological injuries. Neurotherapeutics. 2012;9(1):73–86. doi:10.1007/s13311-011-0092-7.
   PubMed Web of Science ®Google Scholar
• Kabon B, Bacher A, Spiss CK. Therapeutic hypothermia. best pract res clin anesthesiol. Best Pract Res Clin Anaesth. 2003;17(4):551–568. doi:10.1016/S1521-6896(03)00050-8.
   PubMedGoogle Scholar
• Karnad DR, Bhadade R, Verma PK, et al. Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive care Med. 2014;40(6):830–838. doi:10.1007/s00134-014-3278-8
   PubMed Web of Science ®Google Scholar
• Linder A, Russell JA. An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor. Intensive care Med. 2014;40(8):1164–1167. doi:10.1007/s00134-014-3366-9.
   PubMed Web of Science ®Google Scholar
• Saigal S, Kapoor G. Ulinastatin: is it worth using in severe sepsis? Intensive care Med. 2014;40(8):1185. doi:10.1007/s00134-014-3341-5.
   PubMed Web of Science ®Google Scholar
• Runzhong H, Yingjin Z, Jianlan W, et al. Favorable outcome with early and repeated continuous renal replacement therapy in acute necrotizing encephalopathy. Indian J Pediatr. 2022;89(4):412. doi:10.1007/s12098-021-04012-z
   PubMed Web of Science ®Google Scholar
• Zhu HM, Zhang SM, Yao C, et al. The clinical and imaging characteristics associated with neurological sequelae of pediatric patients with acute necrotizing encephalopathy. Front Pediatr. 2021;9:655074. doi:10.3389/fped.2021.655074
   PubMed Web of Science ®Google Scholar
• Opal SM, Lim YP, Cristofaro P, et al. Interα inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. Shock. 2011;35(1):42–44. doi:10.1097/SHK.0b013e3181e83204
   PubMed Web of Science ®Google Scholar
• Wu TJ, Zhang LN, Kang CC. The effect of ulinastatin on disbalance of inflammation and immune status in patients with severe sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25(4):219–223. doi:10.3760/cma.j.issn.2095-4352.2013.04.010.
   PubMedGoogle Scholar
• Chen H, He MY, Li YM. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study. Chin Med J (Engl). 2009;122(8):883–888.
   PubMed Web of Science ®Google Scholar